Board of Directors and Auditor
The Annual General Meeting decided that the Board of Directors will consist of five (5) members. The following members were re-elected to the Board of Directors:
The members of the board of Directors will be paid an annual remuneration of
Authorisation to the board of directors to decide on the repurchase of own shares
The Annual General Meeting resolved, in accordance with the proposal of the Board of Directors, that the Board of Directors is authorised to resolve on the repurchase of the Company's own shares in one or several tranches using the Company's unrestricted shareholders' equity as follows:
The maximum number of own shares to be repurchased is 100,000 shares.
The shares can be repurchased otherwise than in proportion to the shareholdings of the shareholders in public trading arranged by
The authorisation valid until the closing of the next Annual General Meeting, however, no longer than until
Amendment to the shareholders' nomination board's rules of procedure
The Annual General Meeting resolved, in accordance with the Shareholders' Nomination Board's proposal, to approve the amended Shareholder's Nomination Board's Rules of Procedure so that the following paragraph was deleted:
"A person employed by or in the service of the Company or a member of the Board of Directors cannot be appointed as a member of the Nomination Board, with the exception of the Chairman of the Board of Directors who participates in the Board as a non-voting expert member."
Authorisation of the board of directors to resolve on a share issue and an issue of special rights entitling to shares
The general meeting resolved, in accordance with the proposal of the Board of Directors, that the Board of Directors is authorised to resolve on a share issue and an issue of special rights entitling to shares as referred to in Chapter 10 Section 1 of the Companies Act in one or several tranches, either against payment or without payment as follows.
The aggregate amount of shares to be issued, including the shares to be received based on special rights, must not exceed 400,000 shares.
The authorization entitles the Board of Directors to decide on all the terms and conditions related to the issuance of shares and special rights entitling to shares, including the right to deviate from the pre-emptive right of shareholders to subscribe to shares to be issued. It is proposed that the authorisation be used, for example, to pay for company acquisitions, or incentive payments based on the key employees' incentive system, or for other purposes defined by the Board of Directors. In addition, it is proposed that the authorisation would include the right to decide whether the subscription price of the share is subscribed in full or in part in the reserve for invested unrestricted equity or as an increase of the share capital.
The authorisation is valid until the closing of the next Annual General Meeting, however, no longer than
Further enquiries:
Certified advisor,
¹Measured by the amount of financing facilitated. Source: Brismo Market Data (data accessed on 18 June 2020).
https://news.cision.com/fellow-finance-oyj/r/resolutions-of-fellow-finance-plc-s-annual-general-meeting-on-june-17--2020,c3137543
(c) 2020 Cision. All rights reserved., source